Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1

Clinical trial NCT04393753 · COMPLETED

Trial details

NCT number: NCT04393753
Sponsor: 4SC AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Merkel Cell Carcinoma

Start date: 2020-10-13
Primary completion: 2024-02-26
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.